InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Uihlein Richard E, Director. Officer active across 1 companies, notably Galectin Therapeutics INC. Aggregated, 2 disclosures have been logged. The latest transaction was filed on 24 January 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
€30,86117,677 shares@ €1.7458100.0% of flow
Common Stock
SEC:0001133416-22-000043·
€30,86117,677 shares@ €1.74580.022% mcap50.0% of flow
Common Stock
SEC:0001133416-22-000043:0·
2 of 2 declarations
About Uihlein Richard E
Richard E. Uihlein is a Director at GALECTIN THERAPEUTICS INC. He brings extensive experience in corporate governance and strategy. As a director, Richard contributes to the direction and oversight of the company's activities, ensuring they align with best practices and strategic objectives. His expertise is a valuable asset for GALECTIN THERAPEUTICS INC.
